Cliniqon Revenue and Competitors

Dallas, FL USA

Location

N/A

Total Funding

Employee Data

  • Cliniqon has 156 Employees.(i)
  • Cliniqon grew their employee count by 169% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2840%N/AN/A
#2
N/A6632%N/AN/A
#3
$27.3M1298%N/AN/A
#4
N/A6950%N/AN/A
#5
N/A22343%N/AN/A
#6
N/A798%N/AN/A
#7
N/A10645%N/AN/A
#8
$22.1M1645%N/AN/A
#9
N/A5-37%N/AN/A
#10
N/A7421%N/AN/A
Add Company

What Is Cliniqon?

Cliniqon is a rising outsourcing clinical business process management company with an outstanding reputation for delivering unparalleled outcomes to its clients. Our focus is for our partners to have peace of mind knowing that they are assured of guaranteed quality and ensured compliance throughout their journey with us.\n\nOur in-depth healthcare industry expertise empowers us to provide innovative end-to-end solutions to effectively resolve our clients’ CDI, Coding, and billing challenges while helping them enhance their overall business operations. \n\nCliniqon delivers a framework of highly skilled clinical professionals and AI & RPA-driven workflow technology solutions. By leveraging our people, processes, and technology, we make it possible for our clients to reduce operating and capital costs, improve patient satisfaction, recover revenue, and increase productivity\n\nWe help our clients discover innovative approaches to growth. Our strategic processes help organizations across the industry develop a steadfast commitment to becoming more customer-centric, helping them drive purpose and establish better patient experiences.\n\nHOME HEALTH CODING AND QA SERVICES\nHOSPICE CODING AND QA SERVICES\nREVENUE CYCLE MANAGEMENT SERVICES\nREMOTE PATIENT MONITORING SERVICES

keywords:N/A

N/A

Total Funding

156

Number of Employees

N/A

Revenue (est)

169%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.2M156-3%N/A
#2
$43.1M156-2%N/A
#3
$46.3M1568%N/A
#4
$30.9M1563%N/A
#5
$49.8M156-62%N/A